Invirsa, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.invirsa.com
Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy
Phase 2
Recruiting
- Conditions
- Non-center Involved Diabetic Macular EdemaNon-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic RetinopathyDiabetic RetinopathyCenter-involved Diabetic Macular EdemaCenter-involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Invirsa, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT06599684
- Locations
- 🇺🇸
MedTrials, Inc., Dallas, Texas, United States
Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
- First Posted Date
- 2024-04-17
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Invirsa, Inc.
- Target Recruit Count
- 109
- Registration Number
- NCT06370039
- Locations
- 🇺🇸
iuvo BioScience, Rush, New York, United States
Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis
Phase 2
Recruiting
- Conditions
- Acute Infectious Keratoconjunctivitis
- Interventions
- Drug: Vehicle
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Invirsa, Inc.
- Target Recruit Count
- 102
- Registration Number
- NCT05636228
- Locations
- 🇺🇸
Global Research Management, Glendale, California, United States
🇺🇸Foothill Eye Institute, Pasadena, California, United States
🇺🇸Shettle Eye Research, Largo, Florida, United States
Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Invirsa, Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT05586152
- Locations
- 🇺🇸
iuvo BioScience, Rush, New York, United States
© Copyright 2025. All Rights Reserved by MedPath